BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9810695)

  • 1. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease.
    Min BS; Nakamura N; Miyashiro H; Bae KW; Hattori M
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1607-12. PubMed ID: 9810695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.
    Sato N; Zhang Q; Ma CM; Hattori M
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1076-80. PubMed ID: 19801861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells.
    Min BS; Gao JJ; Nakamura N; Hattori M
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):1026-33. PubMed ID: 10923835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV-1 protease activity of lanostane triterpenes from the vietnamese mushroom Ganoderma colossum.
    El Dine RS; El Halawany AM; Ma CM; Hattori M
    J Nat Prod; 2008 Jun; 71(6):1022-6. PubMed ID: 18547117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum.
    el-Mekkawy S; Meselhy MR; Nakamura N; Tezuka Y; Hattori M; Kakiuchi N; Shimotohno K; Kawahata T; Otake T
    Phytochemistry; 1998 Nov; 49(6):1651-7. PubMed ID: 9862140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum.
    Min BS; Gao JJ; Hattori M; Lee HK; Kim YH
    Planta Med; 2001 Dec; 67(9):811-4. PubMed ID: 11745016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical constituents of the spores of Ganoderma lucidum].
    Zhang XQ; Pang GL; Cheng Y; Wang Y; Ye WC
    Zhong Yao Cai; 2008 Jan; 31(1):41-4. PubMed ID: 18589746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells.
    Gao JJ; Min BS; Ahn EM; Nakamura N; Lee HK; Hattori M
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):837-40. PubMed ID: 12045343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum.
    Luo J; Zhao YY; Li ZB
    J Asian Nat Prod Res; 2002 Jun; 4(2):129-34. PubMed ID: 12067158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ganoderma triterpenoids from aqueous extract of Ganoderma lucidum].
    Che XQ; Li SP; Zhao J
    Zhongguo Zhong Yao Za Zhi; 2017 May; 42(10):1908-1915. PubMed ID: 29090550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia.
    Ma C; Nakamura N; Hattori M; Kakuda H; Qiao J; Yu H
    J Nat Prod; 2000 Feb; 63(2):238-42. PubMed ID: 10691716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum.
    Fatmawati S; Shimizu K; Kondo R
    Fitoterapia; 2010 Dec; 81(8):1033-6. PubMed ID: 20603199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lanostane triterpenes from the fruiting bodies of Ganoderma lucidum on adipocyte differentiation in 3T3-L1 cells.
    Lee I; Kim H; Youn U; Kim J; Min B; Jung H; Na M; Hattori M; Bae K
    Planta Med; 2010 Oct; 76(14):1558-63. PubMed ID: 20422507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new triterpenoids from fruiting bodies of fungus Ganoderma lucidum.
    Zhao ZZ; Yin RH; Chen HP; Feng T; Li ZH; Dong ZJ; Cui BK; Liu JK
    J Asian Nat Prod Res; 2015; 17(7):750-5. PubMed ID: 25631072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the ganoderic acid, a new constituents from the fruiting body of Ganoderma lucidum (Fr.) Karst].
    Wang FS; Cai H; Yang JS; Zhang YM; Hou CY; Liu JQ; Zhao MJ
    Yao Xue Xue Bao; 1997 Jun; 32(6):447-50. PubMed ID: 11596326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
    Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
    Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New lanostane-type triterpenoids from Ganoderma applanatum.
    Shim SH; Ryu J; Kim JS; Kang SS; Xu Y; Jung SH; Lee YS; Lee S; Shin KH
    J Nat Prod; 2004 Jul; 67(7):1110-3. PubMed ID: 15270562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterols and triterpenoids from the spores of Ganoderma lucidum.
    Zhang CR; Yang SP; Yue JM
    Nat Prod Res; 2008; 22(13):1137-42. PubMed ID: 18855213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical characteristics of the fungus Ganoderma lucidum and their inhibitory effects on acetylcholinesterase.
    Wei JC; Wang AH; Wei YL; Huo XK; Tian XG; Feng L; Ma XC; Wang C; Huang SS; Jia JM
    J Asian Nat Prod Res; 2018 Oct; 20(10):992-1001. PubMed ID: 28944681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new triterpene from the fruiting bodies of Ganoderma lucidum.
    Chen M; Zhang M; Sun S; Xia B; Zhang HQ
    Yao Xue Xue Bao; 2009 Jul; 44(7):768-70. PubMed ID: 19806918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.